Geode Capital Management, LLC Red Hill Biopharma Ltd. Transaction History

Geode Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$1.65 - $3.12 $25,109 - $47,480	15,218 Added 57.6%	41,637 $104,000
Q4 2021 Feb 11, 2022	SELL	$2.31 - $5.85 $1,552 - $3,931	-672 Reduced 2.48%	26,419 $68,000
Q3 2021 Nov 12, 2021	SELL	$4.55 - $10.36 $627 - $1,429	-138 Reduced 0.51%	27,091 $124,000
Q2 2021 Aug 13, 2021	BUY	$5.98 - $7.51 $15,189 - $19,075	2,540 Added 10.29%	27,229 $187,000
Q1 2021 May 12, 2021	BUY	$6.98 - $11.29 $26,621 - $43,060	3,814 Added 18.27%	24,689 $180,000
Q3 2020 Nov 13, 2020	BUY	$6.34 - $10.83 $5,135 - $8,772	810 Added 4.04%	20,875 $213,000
Q2 2020 Aug 13, 2020	BUY	$4.6 - $8.6 $14,724 - $27,528	3,201 Added 18.98%	20,065 $134,000
Q2 2019 Aug 14, 2019	BUY	$6.34 - $8.8 $22,906 - $31,794	3,613 Added 27.27%	16,864 $109,000
Q4 2018 Feb 13, 2019	BUY	$5.18 - $9.35 $68,640 - $123,896	13,251 New	13,251 $73,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.